The Congressional Academic Medicine Caucus and the Association of American Medical Colleges today sponsored a Capitol Hill briefing to highlight the urgent nationwide need for more physicians to treat substance use disorders. In calling for passage of the AHA-supported Opioid Workforce Act (H.R. 3414/S.2892), the briefing featured remarks from Reps. Brad Schneider, D-Ill., and Susan Brooks, R-Ind., the bill’s lead House sponsors, and Rep. Phil Roe (R-TN), a member of the Energy and Commerce Committee. Panelists included Bradley Allen, M.D., of the Indiana University School of Medicine; Scott Teitelbaum, M.D., of the American Society of Addiction Medicine; and Barbara Allen, executive director of James’ Place, a Maryland-based advocacy group that promotes greater access to care. 

Headline
The Department of Homeland Security July 16 finalized a rule replacing “duration of status” admission for certain nonimmigrant visa classifications, including…
Headline
The House Budget Committee July 16 passed a budget resolution by a 20-14 vote along party lines during a markup, paving the way for a new reconciliation bill…
Headline
The Initiative Intelligence Guide, which focuses on workforce well-being, was released July 15 by the AHA, The Coalition for Physician & APP Well-…
Headline
In this conversation, a team from the University Medical Center New Orleans — LSU School of Medicine’s Benjamin Springgate, M.D., professor of …
Headline
Following an introduction from Michelle Hood, AHA executive vice president and COO, moderator Chris DeRienzo, M.D., AHA senior vice president and chief…
Headline
The AHA July 13 commented on proposals by the Office of Management and Budget and other federal agencies to revise the Uniform Grants Regulation governing…